Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Dogs/Cats - 0.25 to 0.5 mL
FOXO4-DRI is designed to disrupt FOXO4p53 interaction , altering p53 localization and signaling in experimental models
LifeWave Stats & Patented Tech Founded in 2004 Open in over 70 countries X39 pre-launched in 2018 with official launch in early 2019 Company growth from 20 million to $600 million (2020-2024) 3,000% growth rate from 2018-2024 Worlds fastest growing direct sales company Our purpose is to empower you to live in the light, maximizing your human potential, with patented life technology that enhances your life. X39 is a fully patented new technology LifeWave patches are an FDA recognized and compliant General Wellness Product Over 80 clinical studies on all the patches Not a me too product like most companies that sell weight loss, supplements, oils, etc
Research Highlights Exercise-Mimetic Research Preclinical studies suggest SLU-PP-332 can activate aerobic exercise-like gene programs in skeletal muscle models
)
)
